|
1
|
Gates B: Responding to Covid-19 - A
Once-in-a-century pandemic. N Engl J Med. 382:1677–1679.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H,
Wu Y, Zhang L, Yu Z, Fang M, et al: Clinical course and outcomes of
critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China:
A single-centered, retrospective, observational study. Lancet
Respir Med. 8:475–481. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Poston JT, Patel BK and Davis AM:
Management of critically ill adults with COVID-19. JAMA.
323:1839–1841. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Maugeri G, Castrogiovanni P, Battaglia G,
Pippi R, D'Agata V, Palma A, Di Rosa M and Musumeci G: The impact
of physical activity on psychological health during Covid-19
pandemic in Italy. Heliyon. 6(e04315)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ravalli S and Musumeci G: Coronavirus
outbreak in Italy: Physiological benefits of home-based exercise
during pandemic. J Funct Morphol Kinesiol. 5(31)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang
H, Wang T, Zhang X, Chen H, Yu H, et al: Clinical and immunological
features of severe and moderate coronavirus disease 2019. J Clin
Invest. 130:2620–2629. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Walls AC, Park YJ, Tortorici MA, Wall A,
McGuire AT and Veesler D: Structure, function, and antigenicity of
the SARS-CoV-2 spike glycoprotein. Cell. 181:281–292.e6.
2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S,
Zhang Q, Shi X, Wang Q, Zhang L and Wang X: Structure of the
SARS-CoV-2 spike receptor-binding domain bound to the ACE2
receptor. Nature. 581:215–220. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara
H, Geng Q, Auerbach A and Li F: Structural basis of receptor
recognition by SARS-CoV-2. Nature. 581:221–224. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chen Y and Li L: SARS-CoV-2: Virus
dynamics and host response. Lancet Infect Dis. 20:515–516.
2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Pedersen SF and Ho YC: SARS-CoV-2: A storm
is raging. J Clin Invest. 130:2202–2205. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yan R, Zhang Y, Li Y, Xia L, Guo Y and
Zhou Q: . Structural basis for the recognition of SARS-CoV-2 by
full-length human ACE2. Science. 367:1444–1448. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Vaduganathan M, Vardeny O, Michel T,
McMurray J, Pfeffer MA and Solomon SD:
Renin-angiotensin-aldosterone system inhibitors in patients with
Covid-19. N Engl J Med. 382:1653–1659. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lin L, Lu L, Cao W and Li T: Hypothesis
for potential pathogenesis of SARS-CoV-2 infection-a review of
immune changes in patients with viral pneumonia. Emerg Microbes
Infect. 9:727–732. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Fu Y, Cheng Y and Wu Y: Understanding
SARS-CoV-2-mediated inflammatory responses: From mechanisms to
potential therapeutic tools. Virol Sin. 35:266–271. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zheng M and Song L: Novel antibody
epitopes dominate the antigenicity of spike glycoprotein in
SARS-CoV-2 compared to SARS-CoV. Cell Mol Immunol. 17:536–538.
2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tian X, Li C, Huang A, Xia S, Lu S, Shi Z,
Lu L, Jiang S, Yang Z, Wu Y and Ying T: Potent binding of 2019
novel coronavirus spike protein by a SARS coronavirus-specific
human monoclonal antibody. Emerg Microbes Infect. 9:382–385.
2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Cao X: COVID-19: Immunopathology and its
implications for therapy. Nat Rev Immunol. 20:269–270.
2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Arabi YM, Murthy S and Webb S: COVID-19: A
novel coronavirus and a novel challenge for critical care.
Intensive Care Med. 46:833–836. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H,
Wang W, Song H, Huang B, Zhu N, et al: Genomic characterisation and
epidemiology of 2019 novel coronavirus: Implications for virus
origins and receptor binding. Lancet. 395:565–574. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song
ZG, Hu Y, Tao ZW, Tian JH, Pei YY, et al: A new coronavirus
associated with human respiratory disease in China. Nature.
579:265–269. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hoffmann M, Kleine-Weber H, Schroeder S,
Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH,
Nitsche A, et al: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2
and is blocked by a clinically proven protease inhibitor. Cell.
181:271–280.e8. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Xu Z, Shi L, Wang Y, Zhang J, Huang L,
Zhang C, Liu S, Zhao P, Liu H, Zhu L, et al: Pathological findings
of COVID-19 associated with acute respiratory distress syndrome.
Lancet Respir Med. 8:420–422. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bermejo-Martin JF, Almansa R, Menéndez R,
Mendez R, Kelvin DJ and Torres A: Lymphopenic community acquired
pneumonia as signature of severe COVID-19 infection. J Infect.
80:e23–e24. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tsatsakis A, Petrakis D, Nikolouzakis TK,
Docea AO, Calina D, Vinceti M, Goumenou M, Kostoff RN, Mamoulakis
C, Aschner M and Hernández AF: COVID-19, an opportunity to
reevaluate the correlation between long-term effects of
anthropogenic pollutants on viral epidemic/pandemic events and
prevalence. Food Chem Toxicol. 141(111418)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Sarkar C, Mondal M, Torequl Islam M,
Martorell M, Docea AO, Maroyi A, Sharifi-Rad J and Calina D:
Potential therapeutic options for COVID-19: Current status,
challenges, and future perspectives. Front Pharmacol.
11(572870)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kwong KK and Chan ST: The role of carbon
monoxide and heme oxygenase-1 in COVID-19. Toxicol Rep.
7:1170–1171. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Farsalinos K, Niaura R, Le Houezec J,
Barbouni A, Tsatsakis A, Kouretas D, Vantarakis A and Poulas K:
Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of
the nicotinic cholinergic system. Toxicol Rep. 7:658–663.
2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Nasi A, McArdle S, Gaudernack G, Westman
G, Melief C, Rockberg J, Arens R, Kouretas D, Sjölin J and Mangsbo
S: Reactive oxygen species as an initiator of toxic innate immune
responses in retort to SARS-CoV-2 in an ageing population, consider
N-acetylcysteine as early therapeutic intervention. Toxicol Rep.
7:768–771. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Peeri NC, Shrestha N, Rahman MS, Zaki R,
Tan Z, Bibi S, Baghbanzadeh M, Aghamohammadi N, Zhang W and Haque
U: The SARS, MERS and novel coronavirus (COVID-19) epidemics, the
newest and biggest global health threats: What lessons have we
learned. Int J Epidemiol. 49:717–726. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan
S and Yuen KY: Genomic characterization of the 2019 novel
human-pathogenic coronavirus isolated from a patient with atypical
pneumonia after visiting Wuhan. Emerg Microbes Infect. 9:221–236.
2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Weiss SR and Leibowitz JL: Coronavirus
pathogenesis. Adv Virus Res. 81:85–164. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Jimenez-Guardeño JM, Nieto-Torres JL,
DeDiego ML, Regla-Nava JA, Fernandez-Delgado R, Castaño-Rodriguez C
and Enjuanes L: The PDZ-binding motif of severe acute respiratory
syndrome coronavirus envelope protein is a determinant of viral
pathogenesis. PLoS Pathog. 10(e1004320)2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Riou J and Althaus CL: Pattern of early
human-to-human transmission of Wuhan 2019 novel coronavirus
(2019-nCoV), December 2019 to January 2020. Euro Surveill.
25(2000058)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wu JT, Leung K and Leung GM: Nowcasting
and forecasting the potential domestic and international spread of
the 2019-nCoV outbreak originating in Wuhan, China: A modelling
study. Lancet. 395:689–697. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Vink MA, Bootsma MC and Wallinga J: Serial
intervals of respiratory infectious diseases: A systematic review
and analysis. Am J Epidemiol. 180:865–875. 2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong
Y, Ren R, Leung K, Lau E, Wong JY, et al: Early transmission
Ddynamics in Wuhan, China, of novel coronavirus-infected pneumonia.
N Engl J Med. 382:1199–1207. 2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhao S, Lin Q, Ran J, Musa SS, Yang G,
Wang W, Lou Y, Gao D, Yang L, He D, et al: Preliminary estimation
of the basic reproduction number of novel coronavirus (2019-nCoV)
in China, from 2019 to 2020: A data-driven analysis in the early
phase of the outbreak. Int J Infect Dis. 92:214–217.
2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Munster VJ, Koopmans M, van Doremalen N,
van Riel D and de Wit E: A novel coronavirus emerging in China-key
questions for impact assessment. N Engl J Med. 382:692–694.
2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Swerdlow DL and Finelli L: Preparation for
possible sustained transmission of 2019 novel coronavirus: Lessons
from pevious epidemics. JAMA. 323:1129–1130. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Zou L, Ruan F, Huang M, Liang L, Huang H,
Hong Z, Yu J, Kang M, Song Y, Xia J, et al: SARS-CoV-2 viral load
in upper respiratory specimens of infected patients. N Engl J Med.
382:1177–1179. 2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
To KK, Tsang OT, Leung WS, Tam AR, Wu TC,
Lung DC, Yip CC, Cai JP, Chan JM, Chik TS, et al: Temporal profiles
of viral load in posterior oropharyngeal saliva samples and serum
antibody responses during infection by SARS-CoV-2: An observational
cohort study. Lancet Infect Dis. 20:565–574. 2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Lescure FX, Bouadma L, Nguyen D, Parisey
M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati
F, Le Hingrat Q, et al: Clinical and virological data of the first
cases of COVID-19 in Europe: A case series. Lancet Infect Dis.
20:697–706. 2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Navas-Martín SR and Weiss S: Coronavirus
replication and pathogenesis: Implications for the recent outbreak
of severe acute respiratory syndrome (SARS), and the challenge for
vaccine development. J Neurovirol. 10:75–85. 2004.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Skariyachan S, Challapilli SB, Packirisamy
S, Kumargowda ST and Sridhar VS: Recent aspects on the pathogenesis
mechanism, animal models and novel therapeutic interventions for
Middle East Respiratory Syndrome Coronavirus infections. Front
Microbiol. 10(569)2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
van den Brand JM, Smits SL and Haagmans
BL: Pathogenesis of Middle East respiratory syndrome coronavirus. J
Pathol. 235:175–184. 2015.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Millet JK and Whittaker GR: Host cell
proteases: Critical determinants of coronavirus tropism and
pathogenesis. Virus Res. 202:120–134. 2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
von der Thüsen J and van der Eerden M:
Histopathology and genetic susceptibility in COVID-19 pneumonia.
Eur J Clin Invest. 50(e13259)2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Hanley B, Lucas SB, Youd E, Swift B and
Osborn M: Autopsy in suspected COVID-19 cases. J Clin Pathol.
73:239–242. 2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Weiss SR and Navas-Martin S: Coronavirus
pathogenesis and the emerging pathogen severe acute respiratory
syndrome coronavirus. Microbiol Mol Biol Rev. 69:635–664.
2005.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Wan Y, Shang J, Sun S, Tai W, Chen J, Geng
Q, He L, Chen Y, Wu J, Shi Z, et al: Molecular Mechanism for
antibody-dependent enhancement of coronavirus entry. J Virol.
94:e02015–19. 2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Letko M, Marzi A and Munster V: Functional
assessment of cell entry and receptor usage for SARS-CoV-2 and
other lineage B betacoronaviruses. Nat Microbiol. 5:562–569.
2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Davidson AM, Wysocki J and Batlle D:
Interaction of SARS-CoV-2 and other coronavirus with ACE
(Angiotensin-converting enzyme)-2 as their main receptor:
Therapeutic implications. Hypertension. 76:1339–1349.
2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Wrapp D, Wang N, Corbett KS, Goldsmith JA,
Hsieh CL, Abiona O, Graham BS and McLellan JS: Cryo-EM structure of
the 2019-nCoV spike in the prefusion conformation. Science.
367:1260–1263. 2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Zhou J, Chu H, Li C, Wong BH, Cheng ZS,
Poon VK, Sun T, Lau CC, Wong KK, Chan JY, et al: Active replication
of Middle East respiratory syndrome coronavirus and aberrant
induction of inflammatory cytokines and chemokines in human
macrophages: Implications for pathogenesis. J Infect Dis.
209:1331–1342. 2014.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Hamming I, Timens W, Bulthuis ML, Lely AT,
Navis G and van Goor H: Tissue distribution of ACE2 protein, the
functional receptor for SARS coronavirus. A first step in
understanding SARS pathogenesis. J Pathol. 203:631–637.
2004.PubMed/NCBI View Article : Google Scholar
|
|
58
|
To KF and Lo AW: Exploring the
pathogenesis of severe acute respiratory syndrome (SARS): The
tissue distribution of the coronavirus (SARS-CoV) and its putative
receptor, angiotensin-converting enzyme 2 (ACE2). J Pathol.
203:740–743. 2004.PubMed/NCBI View Article : Google Scholar
|
|
59
|
He L, Ding Y, Zhang Q, Che X, He Y, Shen
H, Wang H, Li Z, Zhao L, Geng J, et al: Expression of elevated
levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+
cells in SARS patients: Relation to the acute lung injury and
pathogenesis of SARS. J Pathol. 210:288–297. 2006.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Gu J, Han B and Wang J: COVID-19:
Gastrointestinal manifestations and potential fecal-oral
transmission. Gastroenterology. 158:1518–1519. 2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Xiao F, Tang M, Zheng X, Liu Y, Li X and
Shan H: Evidence for gastrointestinal infection of SARS-CoV-2.
Gastroenterology. 158:1831–1833.e3. 2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Mak J, Chan F and Ng SC: Probiotics and
COVID-19: One size does not fit all. Lancet Gastroenterol Hepatol.
5:644–645. 2020.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Liang W, Feng Z, Rao S, Xiao C, Xue X, Lin
Z, Zhang Q and Qi W: Diarrhoea may be underestimated: A missing
link in 2019 novel coronavirus. Gut. 69:1141–1143. 2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang
F, Gong W, Liu X, Liang J, Zhao Q, et al: Association of cardiac
injury with mortality in hospitalized patients with COVID-19 in
Wuhan, China. JAMA Cardiol. 5:802–810. 2020.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Chen L, Li X, Chen M, Feng Y and Xiong C:
The ACE2 expression in human heart indicates new potential
mechanism of heart injury among patients infected with SARS-CoV-2.
Cardiovasc Res. 116:1097–1100. 2020.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Graham RL, Sparks JS, Eckerle LD, Sims AC
and Denison MR: SARS coronavirus replicase proteins in
pathogenesis. Virus Res. 133:88–100. 2008.PubMed/NCBI View Article : Google Scholar
|
|
67
|
McBride R and Fielding BC: The role of
severe acute respiratory syndrome (SARS)-coronavirus accessory
proteins in virus pathogenesis. Viruses. 4:2902–2923.
2012.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Yu X, Sun S, Shi Y, Wang H, Zhao R and
Sheng J: SARS-CoV-2 viral load in sputum correlates with risk of
COVID-19 progression. Crit Care. 24(170)2020.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Chan JF, Zhang AJ, Yuan S, Poon VK, Chan
CC, Lee AC, Chan WM, Fan Z, Tsoi HW, Wen L, et al: Simulation of
the clinical and pathological manifestations of Coronavirus Disease
2019 (COVID-19) in golden Syrian hamster model: Implications for
disease pathogenesis and transmissibility. Clin Infect Dis.
71:2428–2446. 2020.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Iwasaki A and Pillai PS: Innate immunity
to influenza virus infection. Nat Rev Immunol. 14:315–328.
2014.PubMed/NCBI View Article : Google Scholar
|
|
71
|
van der Poll T and Opal SM: Host-pathogen
interactions in sepsis. Lancet Infect Dis. 8:32–43. 2008.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Asehnoune K, Villadangos J and Hotchkiss
RS: Understanding host-pathogen interaction. Intensive Care Med.
42:2084–2086. 2016.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Streicher F and Jouvenet N: Stimulation of
innate immunity by host and viral RNAs. Trends Immunol.
40:1134–1148. 2019.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Totura AL and Baric RS: SARS coronavirus
pathogenesis: Host innate immune responses and viral antagonism of
interferon. Curr Opin Virol. 2:264–275. 2012.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Gralinski LE, Menachery VD, Morgan AP,
Totura AL, Beall A, Kocher J, Plante J, Harrison-Shostak DC,
Schäfer A, Pardo-Manuel de Villena F, et al: Allelic variation in
the toll-like receptor adaptor protein Ticam2 contributes to
SARS-coronavirus pathogenesis in mice. G3 (Bethesda). 7:1653–1663.
2017.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Channappanavar R, Fehr AR, Vijay R, Mack
M, Zhao J, Meyerholz DK and Perlman S: Dysregulated type I
interferon and inflammatory monocyte-macrophage responses cause
lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe.
19:181–193. 2016.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Page C, Goicochea L, Matthews K, Zhang Y,
Klover P, Holtzman MJ, Hennighausen L and Frieman M: Induction of
alternatively activated macrophages enhances pathogenesis during
severe acute respiratory syndrome coronavirus infection. J Virol.
86:13334–13349. 2012.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Peiris JS and Cheung CY: The macrophage in
the pathogenesis of severe acute respiratory syndrome coronavirus
infection. Hong Kong Med J. 15 (Suppl 6):S21–S25. 2009.PubMed/NCBI
|
|
79
|
Zhou J, Chu H, Chan JF and Yuen KY: Middle
East respiratory syndrome coronavirus infection: Virus-host cell
interactions and implications on pathogenesis. Virol J.
12(218)2015.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Yoshikawa T, Hill T, Li K, Peters CJ and
Tseng CT: Severe acute respiratory syndrome (SARS)
coronavirus-induced lung epithelial cytokines exacerbate SARS
pathogenesis by modulating intrinsic functions of monocyte-derived
macrophages and dendritic cells. J Virol. 83:3039–3048.
2009.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Eppensteiner J, Kwun J, Scheuermann U,
Barbas A, Limkakeng AT, Kuchibhatla M, Elster EA, Kirk AD and Lee
J: Damage- and pathogen-associated molecular patterns play
differential roles in late mortality after critical illness. JCI
Insight. 4(e127925)2019.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Ni L, Ye F, Cheng ML, Feng Y, Deng YQ,
Zhao H, Wei P, Ge J, Gou M, Li X, et al: Detection of
SARS-CoV-2-Specific humoral and cellular immunity in COVID-19
convalescent individuals. Immunity. 52:971–977.e3. 2020.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning
L, Chen L, Li M, Liu Y, Wang G, et al: Reduction and functional
exhaustion of T cells in patients with Coronavirus disease 2019
(COVID-19). Front Immunol. 11(827)2020.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Guo L, Ren L, Yang S, Xiao M, Chang Yang
F, Dela Cruz CS, Wang Y, Wu C, Xiao Y, et al: Profiling early
humoral response to diagnose novel coronavirus disease (COVID-19).
Clin Infect Dis. 71:778–785. 2020.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Chen L, Xiong J, Bao L and Shi Y:
Convalescent plasma as a potential therapy for COVID-19. Lancet
Infect Dis. 20:398–400. 2020.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Chen T, Wu D, Chen H, Yan W, Yang D, Chen
G, Ma K, Xu D, Yu H, Wang H, et al: Clinical characteristics of 113
deceased patients with coronavirus disease 2019: Retrospective
study. BMJ. 368(m1091)2020.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Xie J, Tong Z, Guan X, Du B, Qiu H and
Slutsky AS: Critical care crisis and some recommendations during
the COVID-19 epidemic in China. Intensive Care Med. 46:837–840.
2020.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J,
Wang B, Xiang H, Cheng Z, Xiong Y, et al: Clinical characteristics
of 138 hospitalized patients with 2019 novel coronavirus-infected
pneumonia in Wuhan, China. JAMA. 323:1061–1069. 2020.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Yang F, Shi S, Zhu J, Shi J, Dai K and
Chen X: Analysis of 92 deceased patients with COVID-19. J Med
Virol. 92:2511–2515. 2020.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Giannitsi S, Tsinivizov P, Poulimenos LE,
Kallistratos MS, Varvarousis D, Manolis AJ, Tsamakis K, Rizos E,
Spandidos DA, Tsiptsios D and Triantafyllis AS: [Case Report]
Stress induced (Takotsubo) cardiomyopathy triggered by the COVID-19
pandemic. Exp Ther Med. 20:2812–2814. 2020.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Germain RN: Maintaining system
homeostasis: The third law of Newtonian immunology. Nat Immunol.
13:902–906. 2012.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Channappanavar R and Perlman S: .
Pathogenic human coronavirus infections: Causes and consequences of
cytokine storm and immunopathology. Semin Immunopathol. 39:529–539.
2017.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Nieto-Torres JL, DeDiego ML,
Verdiá-Báguena C, Jimenez-Guardeño JM, Regla-Nava JA,
Fernandez-Delgado R, Castaño-Rodriguez C, Alcaraz A, Torres J,
Aguilella VM and Enjuanes L: Severe acute respiratory syndrome
coronavirus envelope protein ion channel activity promotes virus
fitness and pathogenesis. PLoS Pathog. 10(e1004077)2014.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Bermejo JF and Muñoz-Fernandez MA: Severe
acute respiratory syndrome, a pathological immune response to the
new coronavirus-implications for understanding of pathogenesis,
therapy, design of vaccines, and epidemiology. Viral Immunol.
17:535–544. 2004.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Chousterman BG, Swirski FK and Weber GF:
Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol.
39:517–528. 2017.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Yuen KS, Ye ZW, Fung SY, Chan CP and Jin
DY: SARS-CoV-2 and COVID-19: The most important research questions.
Cell Biosci. 10(40)2020.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Misra DP, Agarwal V, Gasparyan AY and
Zimba O: Rheumatologists' perspective on coronavirus disease 19
(COVID-19) and potential therapeutic targets. Clin Rheumatol.
39:2055–2062. 2020.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Cecconi M, Evans L, Levy M and Rhodes A:
Sepsis and septic shock. Lancet. 392:75–87. 2018.PubMed/NCBI View Article : Google Scholar
|
|
99
|
RECOVERY Collaborative Group. Horby P, Lim
WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N,
Brightling C, Ustianowski A, et al: Dexamethasone in hospitalized
patients with Covid-19-preliminary report. N Engl J Med, 2020.
|
|
100
|
Gourd NM and Nikitas N: Multiple organ
dysfunction syndrome. J Intensive Care Med. 35:1564–1575.
2019.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Padureanu R, Albu CV, Mititelu RR,
Bacanoiu MV, Docea AO, Calina D, Padureanu V, Olaru G, Sandu RE,
Malin RD and Buga AM: Oxidative stress and inflammation
interdependence in multiple sclerosis. J Clin Med.
8(1815)2019.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Laforge M, Elbim C, Frère C, Hémadi M,
Massaad C, Nuss P, Benoliel JJ and Becker C: Tissue damage from
neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol.
20:515–516. 2020.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Sharifi-Rad M, Anil Kumar NV, Zucca P,
Varoni EM, Dini L, Panzarini E, Rajkovic J, TsouhFokou PV, Azzini
E, Peluso I, et al: Lifestyle, oxidative stress, and antioxidants:
Back and forth in the pathophysiology of chronic diseases. Front
Physiol. 11(694)2020.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Sharifi-Rad J, Rodrigues CF, Sharopov F,
Docea AO, Can Karaca A, Sharifi-Rad M, KahveciKarıncaoglu D,
Gülseren G, Şenol E, Demircan E, et al: Diet, Lifestyle and
cardiovascular diseases: Linking pathophysiology to
cardioprotective effects of natural bioactive compounds. Int J
Environ Res Public Health. 17(2326)2020.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Salehi B, Rescigno A, Dettori T, Calina D,
Docea AO, Singh L, Cebeci F, Özçelik B, Bhia M, Dowlati Beirami A,
et al: Avocado-soybean unsaponifiables: A panoply of potentialities
to be exploited. Biomolecules. 10(130)2020.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Salehi B, Capanoglu E, Adrar N, Catalkaya
G, Shaheen S, Jaffer M, Giri L, Suyal R, Jugran AK, Calina D, et
al: Cucurbits Plants: A key emphasis to its pharmacological
potential. Molecules. 24(1854)2019.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He
JX, Liu L, Shan H, Lei CL, Hui D, et al: Clinical characteristics
of coronavirus disease 2019 in China. N Engl J Med. 382:1708–1720.
2020.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Chen N, Zhou M, Dong X, Qu J, Gong F, Han
Y, Qiu Y, Wang J, Liu Y, Wei Y, et al: Epidemiological and clinical
characteristics of 99 cases of 2019 novel coronavirus pneumonia in
Wuhan, China: A descriptive study. Lancet. 395:507–513.
2020.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Langford BJ, So M, Raybardhan S, Leung V,
Westwood D, MacFadden DR, Soucy JR and Daneman N: Bacterial
co-infection and secondary infection in patients with COVID-19: A
living rapid review and meta-analysis. Clin Microbiol Infect.
26:1622–1629. 2020.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Liang W, Guan W, Chen R, Wang W, Li J, Xu
K, Li C, Ai Q, Lu W, Liang H, et al: Cancer patients in SARS-CoV-2
infection: A nationwide analysis in China. Lancet Oncol.
21:335–337. 2020.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Fattahi F and Ward PA: Understanding
immunosuppression after sepsis. Immunity. 47:3–5. 2017.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Shenoy V, Ferreira AJ, Qi Y, Fraga-Silva
RA, Díez-Freire C, Dooies A, Jun JY, Sriramula S, Mariappan N,
Pourang D, et al: The angiotensin-converting enzyme
2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection
against lung fibrosis and pulmonary hypertension. Am J Respir Crit
Care Med. 182:1065–1072. 2010.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Liu L, Qiu HB, Yang Y, Wang L, Ding HM and
Li HP: Losartan, an antagonist of AT1 receptor for angiotensin II,
attenuates lipopolysaccharide-induced acute lung injury in rat.
Arch Biochem Biophys. 481:131–136. 2009.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Zhu Y, Qiu HB, Yang Y, Liu L, Zhao MM,
Chen QH and Guo T: Angiotensin II type 2 receptor expression and
its modulation in angiotensin II induced acute lung injury in rat.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 20:585–587. 2008.PubMed/NCBI(In Chinese).
|
|
115
|
Imai Y, Kuba K and Penninger JM:
Angiotensin-converting enzyme 2 in acute respiratory distress
syndrome. Cell Mol Life Sci. 64:2006–2012. 2007.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Kuba K, Imai Y and Penninger JM:
Angiotensin-converting enzyme 2 in lung diseases. Curr Opin
Pharmacol. 6:271–276. 2006.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Busse LW, Chow JH, McCurdy MT and Khanna
AK: COVID-19 and the RAAS-a potential role for angiotensin II. Crit
Care. 24(136)2020.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Liu J, Zhang PS, Yu Q, Liu L, Yang Y, Guo
FM and Qiu HB: Losartan inhibits conventional dendritic cell
maturation and Th1 andTh17 polarization responses: Νovel mechanisms
of preventive effects on lipopolysaccharide-inducedacute lung
injury. Int J Mol Med. 29:269–276. 2012.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Grasselli G, Zangrillo A, Zanella A,
Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G,
Fumagalli R, et al: Baseline characteristics and outcomes of 1591
patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy
Region, Italy. JAMA. 323:1574–1581. 2020.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Tian S, Hu W, Niu L, Liu H, Xu H and Xiao
SY: Pulmonary pathology of early-phase 2019 novel coronavirus
(COVID-19) pneumonia in two patients with lung cancer. J Thorac
Oncol. 15:700–704. 2020.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Vasarmidi E, Tsitoura E, Spandidos DA,
Tzanakis N and Antoniou KM: Pulmonary fibrosis in the aftermath of
the COVID-19 era. Exp Ther Med. 20:2557–2560. 2020.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Elsayed SM, Reddy MK, Murthy PM, Gupta I,
Valiuskyte M, Sánchez DF and Diaz MA: The possibility and cause of
relapse after previously recovering from COVID-19: A systematic
review. Cureus. 12(e10264)2020.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Gousseff M, Penot P, Gallay L, Batisse D,
Benech N, Bouiller K, Collarino R, Conrad A, Slama D, Joseph C, et
al: Clinical recurrences of COVID-19 symptoms after recovery: Viral
relapse, reinfection or inflammatory rebound. J Infect. 81:816–846.
2020.PubMed/NCBI View Article : Google Scholar
|
